[MAP in the treatment of adenocarcinoma of the endometrium].
D000230:Adenocarcinoma / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D008525:Medroxyprogesterone
Il MAP nella terapia dell'adenocarcinoma dell'endometrio.